QOP
ACIU icon

Quinn Opportunity Partners’s AC Immune ACIU Stock Holding History

Quinn Opportunity Partners’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24K Hold
10,100
– – ﹤0.01% 356
2026
Q1 		$27.8K Hold
10,100
– – ﹤0.01% 357
2025
Q4 		$31.7K Hold
10,100
– – ﹤0.01% 366
2025
Q3 		$29.2K Hold
10,100
– – ﹤0.01% 324
2025
Q2 		$20.5K Hold
10,100
– – ﹤0.01% 351
2025
Q1 		$18.9K Hold
10,100
– – ﹤0.01% 394
2024
Q4 		$27.3K Buy
+10,100
New +$31.6K ﹤0.01% 374

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quinn Opportunity Partners's ACIU Position: Q2 2026 in Review

Quinn Opportunity Partners held its AC Immune (ACIU) position steady in Q2 2026 at 10,100 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

Quinn Opportunity Partners first reported a position in ACIU in Q4 2024 and has held it in 7 quarters since. The position peaked at $31.7K in Q4 2025. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Quinn Opportunity Partners held 10,100 shares of AC Immune worth $24K as of Q2 2026.
  • Quinn Opportunity Partners left its AC Immune share count unchanged in Q2 2026.
  • AC Immune made up ﹤0.01% of Quinn Opportunity Partners's portfolio in Q2 2026, its #356 holding.
  • Quinn Opportunity Partners first reported a position in AC Immune in Q4 2024 and has held it in 7 quarters since.
  • Quinn Opportunity Partners's AC Immune position peaked at $31.7K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.